Elite in Myasthenia Gravis

Dr. Tuan Vu

Neurology
University Medical Service Association Inc
13330 Usf Laurel Dr, 
Tampa, FL 
Elite in Myasthenia Gravis
University Medical Service Association Inc
13330 Usf Laurel Dr, 
Tampa, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Tuan Vu is a Neurologist in Tampa, Florida. Dr. Vu is rated as an Elite provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Myasthenia Gravis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal Muscular Atrophy (SMA), and Spinal and Bulbar Muscular Atrophy.

His clinical research consists of co-authoring 107 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 34 articles and participated in 3 clinical trials in the study of Myasthenia Gravis.

Specialties
Neurology
Licenses
Psychiatry & Neurology in FL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

University Medical Service Association Inc
13330 Usf Laurel Dr, Tampa, FL 33612
Other Locations
USF Dermatology Laboratory
12901 Bruce B Downs Blvd, Tampa,, FL 33612

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Autologous T-Cells Expressing A Chimeric Antigen Receptor Directed To B-Cell Maturation Antigen (BCMA) In Patients With Generalized Myasthenia Gravis (MG)
Autologous T-Cells Expressing A Chimeric Antigen Receptor Directed To B-Cell Maturation Antigen (BCMA) In Patients With Generalized Myasthenia Gravis (MG)
Enrollment Status: Active_not_recruiting
Publish Date: May 28, 2025
Intervention Type: Drug
Study Drug: Descartes-08
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1, Followed by an Open-Label Extension
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1, Followed by an Open-Label Extension
Enrollment Status: Completed
Publish Date: April 25, 2025
Intervention Type: Drug
Study Drug: Pitolisant
Study Phase: Phase 2
A Phase 2a Open-Label Preliminary Safety, Efficacy, and Biomarker Study of WP-0512 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2a Open-Label Preliminary Safety, Efficacy, and Biomarker Study of WP-0512 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Enrollment Status: Active_not_recruiting
Publish Date: April 08, 2025
Intervention Type: Drug
Study Drug: Fasudil (WP-0512)
Study Phase: Phase 2
Evaluation of the Safety, Tolerability, Efficacy and Activity of AMX0035, a Fixed Combination of Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA), for the Treatment of ALS
Evaluation of the Safety, Tolerability, Efficacy and Activity of AMX0035, a Fixed Combination of Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA), for the Treatment of ALS
Enrollment Status: Completed
Publish Date: May 16, 2024
Intervention Type: Other, Drug
Study Phase: Phase 2
A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Biological
Study Drugs: HYQVIA, Intravenous Immunoglobulin G
Study Phase: Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of lGIV-C as a Corticosteroid Sparing Agent in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of lGIV-C as a Corticosteroid Sparing Agent in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
Enrollment Status: Completed
Publish Date: March 30, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) in Symptomatic Subjects With Generalized Myasthenia Gravis
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) in Symptomatic Subjects With Generalized Myasthenia Gravis
Enrollment Status: Completed
Publish Date: March 05, 2019
Intervention Type: Drug
Study Phase: Phase 2
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Enrollment Status: Completed
Publish Date: July 06, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 7 Less Clinical Trials

106 Total Publications

Hydrogen cyanide and hydrocarbons mix on Titan.
Hydrogen cyanide and hydrocarbons mix on Titan.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 23, 2025
Similar Doctors
Distinguished in Myasthenia Gravis
Dr. Allan S. Weiss
Neurology
Distinguished in Myasthenia Gravis
Dr. Allan S. Weiss
Neurology
1201 5th Avenue North, Suite 202, 
Saint Petersburg, FL 
 (26.9 miles away)
727-820-7701
Languages Spoken:
English, Spanish, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Allan Weiss is a Neurologist in Saint Petersburg, Florida. Dr. Weiss is rated as an Advanced provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyneuropathy, Glycogen Storage Disease Type 5, and Trigeminal Neuralgia. Dr. Weiss is currently accepting new patients.

Distinguished in Myasthenia Gravis
Dr. Rebecca L. Hurst
Neurology
Distinguished in Myasthenia Gravis
Dr. Rebecca L. Hurst
Neurology

University Medical Service Association Inc

2 Tampa General Cir, 
Tampa, FL 
 (9.4 miles away)
813-821-8038
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Rebecca Hurst is a Neurologist in Tampa, Florida. Dr. Hurst is rated as an Advanced provider by MediFind in the treatment of Myasthenia Gravis. Her top areas of expertise are Myasthenia Gravis, Stiff Person Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, Spinal and Bulbar Muscular Atrophy, and Gastrostomy. Dr. Hurst is currently accepting new patients.

Advanced in Myasthenia Gravis
Dr. Hera Stephens
Neurology
Advanced in Myasthenia Gravis
Dr. Hera Stephens
Neurology

Office

13330 Usf Laurel Dr Fl 3, 
Tampa, FL 
 (2.3 miles away)
813-396-9478
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Hera Stephens is a Neurologist in Tampa, Florida. Dr. Stephens is rated as an Advanced provider by MediFind in the treatment of Myasthenia Gravis. Her top areas of expertise are Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyneuropathy, Epilepsy, and Seizures.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Vu's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 33 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile